Over 100 prominent companies are currently engaged in developing treatments for osteoarthritis. Among them, Biosplice Therapeutics has drug candidates that have reached the most advanced stage—Phase ...

The global AI in ultrasound imaging market is set to witness a growth rate of 22% in the next 5 years. Growing adoption of AI ...